Clinical Trial Update: Evaluate Bioequivalence of Burotam (1/1 g/Vial) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating bioequivalence of Burotam (1/1 g per vial).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Diseases

Drugs mentioned

• Burotam

Snippet

Sponsor: Yung Shin Pharm. Ind. Co., Ltd. | Conditions: Infectious Diseases | Phase 4 | Status: UNKNOWN